生命科学资讯

House passes bill to reauthorize rare pediatric PRV program; Senate next

FDA adopts agentic AI in latest push to infuse artificial intelligence into agency

Morgan Stanley assumes coverage on 10X Genomics stock with Equalweight rating - Investing.com

Morgan Stanley assumes coverage on Thermo Fisher stock with Overweight rating - Investing.com

Morgan Stanley assumes coverage on 10X Genomics stock with Equalweight rating - Investing.com

New ACIP chair claims Covid-19 vaccines caused cancer, miscarriages

Janux’s prostate cancer immunotherapy’s response rate drops, according to new early-stage data

FDA and Prasad's Covid vaccine death claims lack key details

Key facts: HSBC Raises Thermo Fisher Price Target to $670; VP Files to Sell Shares - TradingView

Regeneron makes $150M bet on Tessera's rare disease gene writing prospect

European Union teams up with Angelini to funnel €150M to European health startups

Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts - ts2.tech

Belite Bio aims for first approval of Stargardt disease treatment with Phase 3 success

UK agrees to boost drug prices to dodge US pharma tariffs

Appointments and advancements for Dec. 1, 2025

Financings for Dec. 1, 2025

In the clinic for Dec. 1, 2025

Other news to note for Dec. 1, 2025

Regulatory actions for Dec. 1, 2025

Regeneron inks gene editing deal with startup Tessera